Treatment patterns in patients with multiple myeloma (MM): A retrospective study using Medicare data.

被引：0
|
作者：
Lin, Peggy L.
Latremouille-Viau, Dominick
Sasane, Medha
Gagnon-Sanschagrin, Patrick
Divan, Hozefa A.
Drea, Edward Joseph
Guerin, Annie
Hari, Parameswaran
机构：
[1] Sanofi Inc, Cambridge, MA USA
[2] Anal Grp Inc, Montreal, PQ, Canada
[3] Sanofi Inc, Bridgewater, NJ USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19506
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
    Kathleen Maignan
    Lola A. Fashoyin-Aje
    Aracelis Z. Torres
    Laura L. Fernandes
    Thomas Gwise
    Shrujal B. Baxi
    James P. Roose
    Donna R. Rivera
    Yuan Li Shen
    Paul G. Kluetz
    Nicole J. Gormley
    Blood Cancer Journal, 12
  • [22] Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
    Maignan, Kathleen
    Fashoyin-Aje, Lola A.
    Torres, Aracelis Z.
    Fernandes, Laura L.
    Gwise, Thomas
    Baxi, Shrujal B.
    Roose, James P.
    Rivera, Donna R.
    Shen, Yuan Li
    Kluetz, Paul G.
    Gormley, Nicole J.
    BLOOD CANCER JOURNAL, 2022, 12 (04)
  • [23] Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada
    Reece, Donna E.
    Masih-Khan, Esther
    Atenafu, Ehetu G.
    Jimenez-Zepeda, Victor H.
    McCurdy, Arleigh
    Song, Kevin
    LeBlanc, Richard
    Sebag, Michael
    White, Darrell
    Cherniawsky, Hannah
    Reiman, Anthony
    Stakiw, Julie
    Louzada, Martha L.
    Kotb, Rami
    Aslam, Muhammad
    Gul, Engin
    Venner, Christopher P.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (04) : 416 - 427
  • [24] Patient characteristics, treatment patterns and outcomes for patients with renal cell carcinoma in England: A retrospective cohort study using data from the National Cancer Registry and treatment and hospital data.
    Das, Prantik
    Clark, Andrew
    Nordstrom, Beth
    Booth, Alison
    Dhokia, Poonam
    Carroll, Robert
    Vaz, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [25] Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front-line regimens using the SEER-Medicare data
    Goto, Daisuke
    Khairnar, Rahul
    Yared, Jean A.
    Yong, Candice
    Romanus, Dorothy
    Onukwugha, Eberechukwu
    Slejko, Julia F.
    CANCER MEDICINE, 2020, 9 (02): : 626 - 639
  • [26] Heparin in the treatment of hyperviscosity syndrome in patients with multiple myeloma (MM)
    Bessmeltsev, SS
    Abdulkadyrov, KM
    Katsadze, YL
    Rukavitsyn, OA
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS179 - PS179
  • [27] RETROSPECTIVE STUDY OF FREQUENCY AND COST OF MULTIPLE MYELOMA (MM) COMPLICATIONS AND TREATMENT RELATED ADVERSE EVENTS (AES)
    Hagiwara, M.
    Panjabi, S.
    Sharma, A.
    Delea, T. E.
    VALUE IN HEALTH, 2016, 19 (07) : A725 - A725
  • [28] Impact of Extended Treatment Interval on the Prognosis of Multiple Myeloma Patients: A Retrospective Study
    Sun, Chao
    Ye, Jian-Nan
    Mao, Jing-Jue
    Ma, Ke-Wa
    Zhou, Xin
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (11) : 592 - 604
  • [29] A Retrospective Database Analysis of Treatment Pathways in US Medicare Patients with Multiple Myeloma Following Sequential Treatment with Lenalidomide and a Proteasome Inhibitor
    Boytsov, Natalie
    Cyhaniuk, Anissa
    Leung, Gary
    Wang, Feng
    Hogea, Cosmina
    Smith, Matthew Lee
    Mudumby, Pallavi
    BLOOD, 2021, 138
  • [30] Treatment patterns and outcomes among elderly patients with chronic myeloid leukemia: An analysis of linked SEER-Medicare data.
    Menzin, J
    Lang, K
    Earle, C
    Glendenning, A
    BLOOD, 2002, 100 (11) : 875A - 875A
12345